Fernando Serrano
Psychiatric/Mental Health · San Diego, CANPI 1083247779
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,432 of the $15,598 with a category attached, or 73.3%. 10 manufacturers reported payments, led by Alkermes, Inc. at 47.5% of the total. Among psychiatric/mental health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 364 payments — averaging $42.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$7K
- Neurocrine Biosciences, Inc.$3K
- Johnson & Johnson$1K
- Teva Pharmaceuticals USA, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$957
- Otsuka America Pharmaceutical, Inc.$798
- plus $2K from 4 others
What the payments were for
- Consulting fees$2,80018%
- Travel & lodging$1,0237%
- Food & beverage$11,43273%
- Education$3432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 103 | $7,402 |
| Neurocrine Biosciences, Inc. | 63 | $2,531 |
| Johnson & Johnson(2 entities) | 39 | $1,304 |
| Teva Pharmaceuticals USA, Inc. | 38 | $1,024 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $957 |
| Otsuka America Pharmaceutical, Inc. | 30 | $798 |
| Vanda Pharmaceuticals Inc. | 20 | $502 |
| E.r. Squibb & Sons, L.L.C. | 13 | $405 |
| Lundbeck LLC | 14 | $362 |
| Indivior Inc. | 12 | $312 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$18,566
- ARISTADA$2,340
- INGREZZA$1,249
- ARISTADA INITIO$585
- INVEGA SUSTENNA$292
- REXULTI$252
- COBENFY$122
- CAPLYTA$109
- Austedo XR$104
How this compares
$15,598 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega TrinzaPaliperidone Palmitate | 11 | $110,186 |
| LybalviOlanzapine/Samidorphan Malate | 98 | $71,511 |
| Abilify MaintenaAripiprazole | 23 | $62,575 |
| VivitrolNaltrexone Microspheres | 26 | $41,941 |
| CaplytaLumateperone Tosylate | 51 | $39,348 |
| TrintellixVortioxetine Hydrobromide | 39 | $7,281 |
| VraylarCariprazine Hcl | 16 | $5,168 |
| Clozapine | 93 | $3,565 |
| Lurasidone Hcl | 102 | $3,293 |
| Aripiprazole | 83 | $3,069 |
| Olanzapine | 200 | $1,629 |
| Divalproex Sodium | 55 | $1,263 |
| Divalproex Sodium ErDivalproex Sodium | 43 | $1,214 |
| Naltrexone Hcl | 44 | $1,186 |
| Prazosin Hcl | 114 | $1,105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Alkermes, Inc.Lybalvi, Vivitrol | $7,402 | $113,451124 claims |
| Johnson & JohnsonInvega Trinza | $1,304 | $110,18611 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $798 | $62,57523 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $957 | $39,34851 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in San Diego
- Kelvin PoonSan Diego$16K
- Rona HausserSan Diego$10K
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.